SKYSCRAPER-03: a phase III study of tiragolumab plus atezolizumab versus durvalumab in locally advanced, unresectable, stage III NSCLC after platinum-based concurrent chemoradiation ☆

Annals of Vascular Surgery · Elsevier

Аннотация

Publication date: November 2026 Source: Annals of Oncology, Volume 37, Issue 11 Author(s): H.A. Wakelee, M.-J. Ahn, J. Bradley, S. Popat, K. Kelly, A.-M. Baird, O. Ozyilkan, J. Yu, S.Y. Lee, N. Yanagitani, M. Johnson, A. Sánchez-Hernández, A. Szczesna, K. Cuppens, E. Yao, C. Parsons, C. Matheny, Z. Zhang, M.N. White, J.J. Hsu

Читать у издателя →

Похожие статьи